Somatropin - Daewoong Pharmaceutical

Drug Profile

Somatropin - Daewoong Pharmaceutical

Alternative Names: Care Tropin - Daewoong; Caretropin

Latest Information Update: 22 Dec 2016

Price : $50

At a glance

  • Originator Daewoong Pharmaceutical
  • Class Growth hormones; Hormonal replacements
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Somatotropin deficiency

Most Recent Events

  • 17 Sep 2014 Somatropin - Daewoong is available for licensing as of 17 Sep 2014.
  • 17 Sep 2014 Registered for Somatotropin deficiency in Philippines (SC)
  • 16 Jul 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top